Ipca Laboratories has announced a conference call to discuss its financial results for the fourth quarter of fiscal year 2026. The event is scheduled for June 1, 2026, providing investors and analysts with an opportunity to review the company's performance and business outlook.

Conference Call Details

The earnings call will be held on Monday, June 1, 2026, from 15:30 hrs to 16:30 hrs IST. This session follows the announcement of the company's Q4FY26 financial results on Friday, May 29, 2026. The discussion will focus on the quarterly earnings and provide a broader business update.

Management Representation

The leadership team representing Ipca Laboratories during the call will include key executives responsible for steering the company's operations. The panel features:

• Mr. A K Jain – Managing Director
• Mr. Harish Kamath – Corporate Counsel & Company Secretary

Access Information

Dam Capital Advisors Ltd. will host the conference call. Participants can join the discussion using the universal access numbers provided below. The company recommends dialing in at least 5 to 10 minutes prior to the scheduled start time to ensure a timely connection.

These lines are accessible from all networks and countries. For those requiring further information or assistance regarding the event, contact details for the company and the advisory firm have been made available.

Ipca Laboratories has informed the stock exchanges of an upcoming Board of Directors meeting scheduled for Friday, May 29, 2026. The intimation has been filed pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The Board meeting has been convened to consider the following key items:

Trading Window Closure

In connection with the forthcoming Board meeting, Ipca Laboratories had previously communicated, vide a letter dated March 16, 2026, the closure of the trading window for insiders. As per the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the company by insiders has remained closed with effect from April 1, 2026. The window will remain closed until 48 hours after the declaration of the company's audited financial results for the 4th quarter and financial year ended March 31, 2026, i.e., till May 31, 2026.

The board meeting notice was signed by Harish P. Kamath, Corporate Counsel & Company Secretary of Ipca Laboratories, and filed with both BSE Ltd. and National Stock Exchange of India Limited on May 4, 2026.